Fer M F, McKinney T D, Richardson R L, Hande K R, Oldham R K, Greco F A
Am J Med. 1981 Oct;71(4):704-18. doi: 10.1016/0002-9343(81)90241-2.
Various renal complications occur during the course of neoplastic disease. The therapeutic and prognostic implications differ according to the reversibility of both the underlying malignancy and the superimposed complications in the kidney. Since the mechanisms of renal failure vary significantly in patients with different types of malignancy, it is essential to avoid generalizations about etiologic factors or likely outcomes of the disease processes. The pathophysiologic abnormalities should be determined in each patient, and the reversibility of both the neoplastic and problems assessed before therapeutic decisions are made. This often requires a team effort by the internist, oncologist, nephrologist, urologist and, most importantly, the patient.
在肿瘤疾病过程中会出现各种肾脏并发症。根据潜在恶性肿瘤的可逆性以及肾脏叠加并发症的情况,其治疗和预后意义有所不同。由于不同类型恶性肿瘤患者的肾衰竭机制差异很大,因此避免对病因或疾病过程的可能结果进行一概而论至关重要。应确定每位患者的病理生理异常情况,并在做出治疗决策之前评估肿瘤及相关问题的可逆性。这通常需要内科医生、肿瘤学家、肾病学家、泌尿科医生,以及最重要的患者共同努力。